SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-12-010469
Filing Date
2012-02-16
Accepted
2012-02-16 12:53:24
Documents
2
Group Members
SCHRODER INVESTMENT MANAGEMENT LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a12-5213_3sc13ga.htm SC 13G/A 98428
2 GRAPHIC g52133bei001.jpg GRAPHIC 2708
  Complete submission text file 0001104659-12-010469.txt   103994
Mailing Address 875 THIRD AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 875 THIRD AVENUE, 22ND FLOOR NEW YORK NY 10022 212-641-3800
SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC/ DE (Filed by) CIK: 0001105005 (see all company filings)

IRS No.: 134064414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Subject) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85529 | Film No.: 12618701
SIC: 2834 Pharmaceutical Preparations